Reference & evidence system
Evidence Library
Every source used across the atlas, classified by evidence level. PubMed-indexed entries carry metadata retrieved directly from PubMed — identifiers are never generated. Where no DOI or PMID exists, the card states "Identifier not available".
36 of 36 references
WHO Classification of Tumours Editorial Board. IARC / World Health Organization · 2022
The authoritative international classification of head and neck, odontogenic and salivary gland tumours. Current terminology on this site follows this edition.
IARC / WHO. IARC · 2022
Continuously updated online edition of the WHO head and neck tumour classification.
Skálová A, Hyrcza MD, Leivo I. Head and neck pathology · 2022 · 16(1):40-53
Summary of changes to salivary gland tumours in the 5th edition WHO classification of head and neck tumours.
Vered M, Wright JM. Head and neck pathology · 2022 · 16(1):63-75
Summary of odontogenic and maxillofacial bone tumour changes in the 5th edition WHO classification.
Nanda A, Tedbirt B, Bodemer C et al.. Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 · 40(7):1137-1161
European S2k guideline on the management of autoimmune blistering diseases.
Ruggiero SL, Dodson TB, Aghaloo T et al.. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2022 · 80(5):920-943
AAOMS position paper defining staging and management of medication-related osteonecrosis of the jaw.
Warnakulasuriya S, Kujan O, Aguirre-Urizar JM et al.. Oral diseases · 2021 · 27(8):1862-1880
WHO collaborating centre consensus on nomenclature and classification of oral potentially malignant disorders.
Javaid MK, Boyce A, Appelman-Dijkstra N et al.. Orphanet journal of rare diseases · 2019 · 14(1):267
International consensus best-practice guidelines for fibrous dysplasia / McCune-Albright syndrome.